AXOFT, INC.
Last verified 2026-05-08. JSON
| Total raised | $34.2M |
|---|---|
| Latest round | Funding round, $34.2M, 2026-04-22 |
| Founded | 2021 |
| Headquarters | Cambridge, MA, USA |
| Industry | biotech |
| Stage | unknown |
| Website | axoft.us |
Axoft develops a bioinspired brain-computer interface implant that mimics the soft mechanical properties of brain tissue for long-term neural recording. It serves neuroscience researchers and patients needing durable neural interfaces. Its differentiator is a Fleuron-based implant a million times softer than rigid electronics while keeping ultra-high electrode density.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-04-22 | Funding round | $34.2M | undisclosed |
Detected tech stack
LottieFiles 5.6.6, cdnjs, Cloudflare
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $34.2M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $34.2M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | axoft.us, read 2026-05-08 |
| Description | self-reported | axoft.us, read 2026-05-08 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $34.2M, 2026-04-22 → Funding round, $34.2M, 2026-04-22, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $34.2M, 2026-04-22 → Funding round, $34.2M, 2026-04-22 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes